STERIS Segment operating income — Segment operating income increased by 1.8% to $343.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.2%, from $320.00M to $343.10M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or stronger pricing power within that specific business unit, while a decrease may indicate rising costs or competitive pressure.
This metric represents the profit generated by a specific business segment after deducting direct operating expenses and...
Comparable to segment-level EBIT or operating profit reported by other diversified medical technology and industrial service companies.
ste_segment_segment_operating_income_segment_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $222.23M | $278.54M | $289.89M | $264.77M | $285.34M | $290.65M | $265.74M | $278.10M | $304.23M | $285.44M | $294.50M | $320.00M | $337.10M | $343.10M |
| QoQ Change | — | +25.3% | +4.1% | -8.7% | +7.8% | +1.9% | -8.6% | +4.7% | +9.4% | -6.2% | +3.2% | +8.7% | +5.3% | +1.8% |
| YoY Change | — | — | — | +19.1% | +2.4% | +0.3% | +0.4% | -2.5% | +4.7% | +7.4% | +5.9% | +5.2% | +14.5% | +7.2% |